Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Insmed Q3 GAAP EPS $(1.11) Beats $(1.12) Estimate, Sales $79.07M Miss $79.13M Estimate

Author: Benzinga Newsdesk | October 26, 2023 07:38am
Insmed (NASDAQ:INSM) reported quarterly losses of $(1.11) per share which beat the analyst consensus estimate of $(1.12) by 0.89 percent. This is a 1.83 percent decrease over losses of $(1.09) per share from the same period last year. The company reported quarterly sales of $79.07 million which missed the analyst consensus estimate of $79.13 million by 0.07 percent. This is a 16.75 percent increase over sales of $67.73 million the same period last year.

Posted In: INSM


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist